(MedPage Today) — Aimed at boosting use of “high-performing” drugs
Uncategorized
Cumulative results of Xen gel stent implantation in Europe promising for US
FORT LAUDERDALE, Fla. — If approved by the FDA, Allergan’s Xen45 implant will be an additional tool to surgically manage glaucoma in the U.S., Davinder S. Grover, MD, MPH, said at the American Glaucoma Society meeting, where he reported on the international experience of the first 975 glaucomatous eyes treated with any one of three iterations of the gel stent. At 12 months, “for all comers,” there is nearly a 33% reduction in IOP and a reduction of 1.7 glaucoma medications, Grover said. Efficacy was similar to that of traditional glaucoma surgery with fewer complications.
Uncategorized
VIDEO: Surgeon talks about causes, explantaion of opacified IOLs
ATHENS, Greece — At the European Society of Cataract and Refractive Surgeons winter meeting, Simonetta Morselli, MD, discusses causes of opacification and techniques for successful IOL explantation and replacement.
Research findings may provide highly effective therapeutic strategy for treatment of Alzheimer’s, AMD
For the first time, researchers at LSU Health New Orleans have shown that a protein critical to the body’s ability to remove waste products from the brain and retina is diminished in age-related macular degeneration, after first making the discovery in…
Rich Hospital Donors Not Protected by HIPAA
(MedPage Today) — Apparently, privacy rules don’t apply to certain patients, says Edwin Leap, MD
Uncategorized
Smart Vision Labs receives CE mark for SVOne in Europe
Smart Vision Labs has received CE mark approval for SVOne in Europe, according to a press release. SVOne, an FDA class 1 exempt device, is a hand-held Shack-Hartmann wavefront aberrometer that measures objective refractive error in children and adults.